[关键词]
[摘要]
目的:探讨:E1A:基因对人鼻咽癌CNE2细胞裸鼠移植瘤生长的抑制作用和对放疗的增敏作用及其相关机制。方法:以腺病毒为载体,将:E1A:基因导入CNE2细胞,获得含:E1A:的阳性克隆。通过裸鼠致瘤实验,观察:E1A:基因的抑瘤作用。观察:E1A:基因疗法及其与放疗联合应用对CNE2细胞裸鼠移植瘤的疗效。RTPCR法检测:E1A:基因治疗对:P53:基因表达的影响。结果:建立稳定转染AdE1A的CNE2阳性细胞克隆(CNE2AdE1A),CNE2AdE1A组小鼠细胞移植瘤较CNE2组和CNE2Adβgal组(稳定转染Adβgal对照质粒的CNE2细胞)成瘤时间晚、肿瘤小。单纯放疗、单纯AdE1A基因治疗及AdE1A+放疗3种治疗方法均可抑制CNE2裸鼠移植瘤的生长,抑瘤率分别为(60.32±5.34)%、(70.53±6.12)%和(97.15±4.87)%。:E1A:基因治疗能上调鼻咽癌组织中:P53:的表达。结论::E1A:可抑制人鼻咽癌细胞裸鼠移植瘤的生长并增加其对放疗的敏感性,该作用可能与:E1A:上调:P53:基因的表达有关。
[Key word]
[Abstract]
Objective:To study the inhibitory effect of :E1A: gene on the growth of tumors in nude mice implanted with nasopharygeal carcinoma CNE2 cells and its promotion effect on the radiosensitivity of CNE2implanted tumors, and to investigate the related mechanism. :Methods: ::E1A: gene was transfected into CNE2 cells using adenovirus system, and stable :E1A: positive clones were established. The inhibitory effect of :E1A: on tumor formationability of CNE2 cells was observed in nude mice. The efficacy of :E1A: gene therapy with or without radiotherapy against CNE2 cellimplanted tumors was evaluated. The effect of :E1A: gene therapy on the expression of :P53: was detected by RTPCR. :Results: :CNE2 cells stably transfected with :E1A: gene (CNE2AdE1A)were successfully established. The tumor formation time was later and tumor size was smaller in CNE2AdE1A cellimplanted mice compared with those in CNE2 cell and CNE2Adβgal cellimplanted mice (CNE2 cells stably transfected with Adβgal). Radiotherapy, :E1A: gene therapy and :E1A: gene+radiotherapy all suppressed the growth of implanted tumors, with the tumor suppression rates being (60.32±5.34)%, (7053±6.12)%, and (97.15±4.87)%, respectively. :E1A: gene therapy significantly increased the expression of :P53 : gene in tumor tissues. :Conclusion: ::E1A: can inhibit the growth of tumors in mice implanted with nasopharygeal carcinoma cells, and enhance its sensitivity to radiotherapy, which may be related to the increased expression of :P53: gene in tumor tissues.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No. 30400118)